Genetic and functional analyses of early growth response (EGR) family genes in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 39, Issue 1, 2012, Pages 149-155

  Cheng, Min Chih ^a   Chuang, Yang An ^a   Lu, Chao Lin ^b   Chen, Yu Jung ^b   Luu, Sy Ueng ^c   Li, Jun Ming ^c   Hsu, Shih Hsin ^a   Chen, Chia Hsiang ^d,e,f  

^a YULI VETERANS HOSPITAL   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Association; EGR family genes; Haplotype; Promoter assay; Schizophrenia

Indexed keywords

EARLY GROWTH RESPONSE FACTOR; MESSENGER RNA;

ADULT; ARTICLE; CONTROLLED STUDY; EGR GENE; EGR1 GENE; EGR2 GENE; EGR3 GENE; EGR4 GENE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PROMOTER REGION; REPORTER GENE; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; FEMALE; GENES, REPORTER; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 84864497774     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.06.004     Document Type: Article

References (41)

1. Abel K.M., Drake R., Goldstein J.M. Sex differences in schizophrenia. Int Rev Psychiatry 2010, 22:417-428.
2. Alberini C.M. Transcription factors in long-term memory and synaptic plasticity. Physiol Rev 2009, 89:121-145.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Baumgartel K., Genoux D., Welzl H., Tweedie-Cullen R.Y., Koshibu K., Livingstone-Zatchej M., et al. Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci 2008, 11:572-578.
5. Cheng M.C., Liao D.L., Hsiung C.A., Chen C.Y., Liao Y.C., Chen C.H. Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. Int J Neuropsychopharmacol 2008, 11:207-216.
6. Cho S.J., Kang M.J., Homer R.J., Kang H.R., Zhang X., Lee P.J., et al. Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J Biol Chem 2006, 24:8161-8168.
7. Coba M.P., Valor L.M., Kopanitsa M.V., Afinowi N.O., Grant S.G. Kinase networks integrate profiles of n-methyl-d-aspartate receptor-mediated gene expression in hippocampus. J Biol Chem 2008, 283:34101-34107.
8. Gallitano-Mendel A., Izumi Y., Tokuda K., Zorumski C.F., Howell M.P., Muglia L.J., et al. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 2007, 148:633-643.
9. Gitenay D., Baron V.T. Is EGR1 a potential target for prostate cancer therapy?. Future Oncol 2009, 5:993-1003.
10. Gómez-Martín D., Díaz-Zamudio M., Galindo-Campos M., Alcocer-Varela J. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun Rev 2010, 9:454-458.
11. Harrison P.J., Tunbridge E.M. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 2008, 33:3037-3045.
12. Jones M.W., Errington M.L., French P.J., Fine A., Bliss T.V., Garel S., et al. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci 2001, 4:289-296.
13. Kalinichev M., Robbins M.J., Hartfield E.M., Maycox P.R., Moore S.H., Savage K.M., et al. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:414-422.
14. Kim S.H., Song J.Y., Joo E.J., Lee K.Y., Ahn Y.M., Kim Y.S. EGR3 as a potential susceptibility gene for schizophrenia in Korea. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1355-1360.
15. Kyogoku C., Yanagi M., Nishimura K., Sugiyama D., Morinobu A., Fukutake M., et al. Association of calcineurin A gamma subunit (PPP3CC) and early growth response 3 (EGR3) gene polymorphisms with susceptibility to schizophrenia in a Japanese population. Psychiatry Res 2011, 185:16-19.
16. Li L., Yun S.H., Keblesh J., Trommer B.L., Xiong H., Radulovic J., et al. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol Cell Neurosci 2007, 35:76-88.
17. Liu B.C., Zhang J., Wang L., Li X.W., Wang Y., Ji J., et al. No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:506-509.
18. Madden S.L., Rauscher F.J. Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc-finger gene products. Ann N Y Acad Sci 1993, 684:75-84.
19. Mendrek A., Stip E. Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?. Expert Rev Neurother 2011, 11:951-959.
20. Näkki R., Sharp F.R., Sagar S.M., Honkaniemi J. Effects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 1996, 45:13-27.
21. Nawa H., Takahashi M., Patterson P.H. Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol Psychiatry 2000, 5:594-603.
22. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A 1992, 89:4270-4274.
23. Niemann A., Berger P., Suter U. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 2006, 8:217-242.
24. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 1999, 22:167-173.
25. Poirier R., Cheval H., Mailhes C., Charnay P., Davis S., Laroche S. Paradoxical role of an egr transcription factor family member, egr2/krox20, in learning and memory. Front Behav Neurosci 2007, 1:1-12.
26. Poirier R., Cheval H., Mailhes C., Garel S., Charnay P., Davis S., et al. Distinct functions of egr gene family members in cognitive processes. Front Neurosci 2008, 2:47-55.
27. Purcell S., Cherny S.S., Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
28. Robertson G.S., Hori S.E., Powell K.J. Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci 2006, 31:157-167.
29. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 2005, 6:472-480.
30. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
31. Song X.Q., Lv L.X., Li W.Q., Hao Y.H., Zhao J.P. The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia. Biol Psychiatry 2009, 15:481-488.
32. Sukhatme V.P. Early transcriptional events in cell growth: the Egr family. J Am Soc Nephrol 1990, 1:859-866.
33. Sukhatme V.P. The Egr family of nuclear signal transducers. Am J Kidney Dis 1991, 17:615-618.
34. Swanberg S.E., Nagarajan R.P., Peddada S., Yasui D.H., LaSalle J.M. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Hum Mol Genet 2009, 18:525-534.
35. Uvarov P., Ludwig A., Markkanen M., Rivera C., Airaksinen M.S. Upregulation of the neuron-specific K+/Cl- cotransporter expression by transcription factor early growth response 4. J Neurosci 2006, 26:13463-13473.
36. Verma V., Rasmussen K., Dawe G.S. Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience 2006, 143:573-585.
37. Verma V., Lim E.P., Han S.P., Nagarajah R., Dawe G.S. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Neurosci Res 2007, 57:17-28.
38. Voisey J., Swagell C.D., Hughes I.P., Lawford B.R., Young R.M., Morris C.P. HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association. Eur Psychiatry 2010, 10.1016/j.eurpsy.2010.08.004.
39. Wieland G.D., Nehmann N., Muller D., Eibel H., Siebenlist U., Suhnel J., et al. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-κB p50 and p65. J Cell Sci 2005, 118:3203-3212.
40. Yamada K., Gerber D.J., Iwayama Y., Ohnishi T., Ohba H., Toyota T., et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia. Proc Natl Acad Sci U S A 2007, 104:2815-2820.
41. Zipfel P.F., Decker E.L., Holst C., Skerka C. The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor. Biochim Biophys Acta 1997, 1354:134-144.